| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
|
Yoda, Satoshi
|
|
2010
|
67 |
3 |
p. 717-722
|
artikel
|
| 2 |
A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas
|
Hill, Marisa E.
|
|
2010
|
67 |
3 |
p. 511-517
|
artikel
|
| 3 |
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination
|
Ramanathan, Ramesh K.
|
|
2010
|
67 |
3 |
p. 503-509
|
artikel
|
| 4 |
Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists
|
Percie du Sert, N.
|
|
2010
|
67 |
3 |
p. 667-686
|
artikel
|
| 5 |
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect
|
Urien, Saik
|
|
2010
|
67 |
3 |
p. 597-603
|
artikel
|
| 6 |
Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs
|
Heshe, Dirk
|
|
2010
|
67 |
3 |
p. 647-655
|
artikel
|
| 7 |
Epilepsy in the cancer patient
|
Kargiotis, Odysseas
|
|
2011
|
67 |
3 |
p. 489-501
|
artikel
|
| 8 |
Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC)
|
Hamaguchi, Tetsuya
|
|
2010
|
67 |
3 |
p. 587-596
|
artikel
|
| 9 |
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
|
Goldstein, David
|
|
2010
|
67 |
3 |
p. 519-525
|
artikel
|
| 10 |
In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines
|
Cheng, Hua
|
|
2010
|
67 |
3 |
p. 637-646
|
artikel
|
| 11 |
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents
|
Gravett, Andrew M.
|
|
2010
|
67 |
3 |
p. 569-577
|
artikel
|
| 12 |
Marginal increase of sunitinib exposure by grapefruit juice
|
Erp, Nielka P. van
|
|
2010
|
67 |
3 |
p. 695-703
|
artikel
|
| 13 |
Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer
|
Kim, Jin Young
|
|
2010
|
67 |
3 |
p. 527-532
|
artikel
|
| 14 |
Noscapine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo
|
Liu, Meng
|
|
2010
|
67 |
3 |
p. 605-612
|
artikel
|
| 15 |
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
|
Daud, A. I.
|
|
2010
|
67 |
3 |
p. 657-666
|
artikel
|
| 16 |
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)
|
Kraut, Eric H.
|
|
2010
|
67 |
3 |
p. 579-586
|
artikel
|
| 17 |
Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer
|
Masuda, Noriyuki
|
|
2010
|
67 |
3 |
p. 533-542
|
artikel
|
| 18 |
Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases
|
Yamaguchi, Tatsuro
|
|
2010
|
67 |
3 |
p. 629-635
|
artikel
|
| 19 |
Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
|
Vici, Patrizia
|
|
2010
|
67 |
3 |
p. 687-693
|
artikel
|
| 20 |
Plasma disposition of capecitabine and its metabolites 5′DFCR and 5′DFUR in a standard and dose-intensified monotherapy regimen
|
Czejka, Martin
|
|
2010
|
67 |
3 |
p. 613-619
|
artikel
|
| 21 |
Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA)
|
Basu, Hirak S.
|
|
2010
|
67 |
3 |
p. 705-715
|
artikel
|
| 22 |
Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice
|
Gu, Yongchuan
|
|
2010
|
67 |
3 |
p. 543-555
|
artikel
|
| 23 |
Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization
|
Lopez, Emiliano S.
|
|
2010
|
67 |
3 |
p. 723-728
|
artikel
|
| 24 |
The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid
|
Romani, Antonello A.
|
|
2010
|
67 |
3 |
p. 557-567
|
artikel
|
| 25 |
Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas
|
Sun, Weijing
|
|
2010
|
67 |
3 |
p. 621-627
|
artikel
|
Tijdschrift beschrijving